Cell-based Assay Market Review: Unveiling Market ChallengesPosted by Roger on January 4th, 2024 Cell-based assays help in studying the potential toxicity or efficacy of drugs, biologics, and therapeutics by testing their effects on live cells. They allow scientists to understand how a substance may affect the process of cells. This is crucial during drug development to ensure safety and effectiveness. The need to screen therapeutics and biologics for potential toxicity and efficacy has increased significantly in recent years owing to rising R&D investments in pharmaceutical and biotechnology companies. Threat of new entrants: The cell-based assay market requires high capital investment for R&D which limits the threat of new entrants. However, availability of new technologies can pose potential threat to existing players. Bargaining power of buyers: Numerous global players and availability of substitute products provides buyers with high bargaining power. Buyers can negotiate on price and demand customized solutions. Bargaining power of suppliers: Suppliers operating in the market include raw material suppliers and technology providers. Suppliers have moderate bargaining power due to availability of substitutes and established buyer-supplier relationships. Threat of new substitutes: Introduction of new technologies like microfluidics, imaging solutions, label-free detection poses threat of substitution. However, cell-based assays are established laboratory methods limiting impact of substitutes. Competitive rivalry: Presence of global established players intensifies competition. Players differentiate through product innovation, service offerings, applications and strategic collaborations/acquisitions. Strengths: Established market with wide application in drug discovery & toxicity testing. Technological advancements improving efficiency, throughput and usability. Weaknesses: High capital investment requirements. Require skilled professionals limiting adoption among small labs. Opportunities: Emerging economies provide growth opportunities. Application expansion in personalized medicine, stem cell research presents opportunities. Threats: Stringent regulations constrain market growth. Alternate methods’ adoption may impact sales. Intense competition affects pricing and market share. Regional analysis: North America dominates currently due to presence of major players, funding availability and advanced research infrastructure. Asia Pacific is fastest growing region on back of rising healthcare spending, outsourcing of clinical trials and increasing biotech research. Key players: Key players operating in the cell-based assay market are DiscoverX Corporation, Becton, Dickinson and Company, cell Signaling Technology, Inc., Becton, Danaher Corporation, Thermo Fisher Scientific, Inc., Cisbio Bioassays, Merck & Co., and PerkinElmer, Inc. and others. DiscoverX offers multiple cell-based assay services and kits for applications including ion channel and GPCR screening. BD focuses on providing reagents, microplates and imaging solutions. Like it? Share it!More by this author |